Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation
Crossref DOI link: https://doi.org/10.1186/s12943-017-0607-x
Published Online: 2017-02-08
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tang, Xiaoyun
Wang, Xianyan
Zhao, Yuan Y.
Curtis, Jonathan M.
Brindley, David N.
Funding for this research was provided by:
Canadian Breast Cancer Foundation
Canadian Cancer Society Research Institute